Jacob Pontoppidan Thyssen

This trial tests whether an oral medication called roflumilast can reduce the severity of chronic hand eczema in adults. Participants with moderate to severe hand eczema will receive either roflumilast or a placebo for 16 weeks, followed by a period where everyone gets the active…